WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate...
Chinese online B2C pharmacy and healthcare services platform Jianke has announced that it has successfully closed a...
Singapore - Eisai and collaboration partner Merck announce that the China National Medical Products Administration ...
China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the Nat...
Chinese researchers say they have developed an artificial intelligence (AI) model with medical imaging to accurately det...
Boehringer Ingelheim (BI) and Tsinghua University in Beijing have announced a collaboration aiming to research and devel...
Asia Pacific is predicted to be the fastest growing market for synthetic biology from 2018 to 2025, driving increased de...
Bio-Thera Solutions, a global biopharmaceutical company recently announced that the China National Drug Administration (...
XingImaging LLC, a radiopharmaceutical production and positron emission tomography (PET) acquisition company operating i...
WeDoctor, Mason Group and Aldworth Management have agreed to pay up to $510 million to acquire an 89.5 per cent stake in...
Suven Life Sciences has said that it has been granted a product patent each by China and Eurasia corresponding to a new ...
Qiming Capital and Hillhouse Capital recently led a $55 million series C round in Jacobio Pharmaceuticals, a Beijing-bas...
Ascletis Pharma Inc. has announced that Mr. Joshua Zhongbao Ling joined Ascletis as Vice President of Finance. Mr. Ling ...
China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor recently announced its strategic partnership...
DNAnexus, the global leader in genome informatics and data management, today announced details of an opportun...
China's commercial-stage biopharmaceutical company BeiGene, recently announced the acceptance by the Ch...
Singapore – ECON Healthcare Group signed a Memorandum of Understanding (MOU) with Chongqing Civil Affairs Bureau u...
Strategia Holdings, LLC has announced a strategic partnership alliance with JS InnoPharm (Shanghai), Ltd. to facilitate ...
Mabpharm, a CDH Investments-backed Chinese biopharmaceutical firm has filed for an initial public offering in Hong ...
China Biologic Products Holdings, a leading fully integrated plasma-based biopharmaceutical company in China, announced ...
GL Capital, a healthcare-focused value-driven investment management group in China, has invested $12.5 million in UK-lis...
The Xu lab at Shanghai University's iHuman Institute has deciphered the high-resolution crystal structure of the fi...
At the end of 2017, Chongqing Food and Drug Administration of China Food and Drug Administration (CFDA) officially appro...
IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics tech...
Harbour BioMed has announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharma...
